Literature DB >> 16773269

Leg muscle involvement in facioscapulohumeral muscular dystrophy assessed by MRI.

David B Olsen1, Peter Gideon, Tina Dysgaard Jeppesen, John Vissing.   

Abstract

Using MRI, we evaluated the degree of involvement of muscles in the lower extremities of 18 unselected patients with facioscapulohumeral muscular dystrophy (FSHD). Findings were correlated with fragment size of the mutated gene, age, disease duration and muscle power. Most affected muscles were the hamstrings followed by the tibialis anterior and the medial gastrocnemius. The vastus-, gluteal- and peroneal muscles were the most unaffected, and the psoas muscle did not show evidence of involvement in any of the investigated subjects. Asymmetric involvement was evident in 15% of the investigated muscles on MRI and 6% on manual muscle strength testing. MRI findings in muscle tended to correlate with disease duration (r = 0.49; p < 0.05), but not with gene fragment size or age. MRI disclosed involvement of muscles performing hip flexion and ankle dorsal flexion that could not be detected by manual muscle strength testing. Otherwise, there was a close correlation (approximately r = 0.75; p < 0.0001) between muscle strength and MRI severity score for other muscle groups. The present study shows that MRI may disclose muscle involvement in FSHD that is not apparent on manual muscle testing, and suggests that MRI of muscle may be an important assessment tool in clinical trials involving patients with FSHD.

Entities:  

Mesh:

Year:  2006        PMID: 16773269     DOI: 10.1007/s00415-006-0230-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  11 in total

Review 1.  Facioscapulohumeral dystrophy.

Authors:  J T Kissel
Journal:  Semin Neurol       Date:  1999       Impact factor: 3.420

Review 2.  Molecular diagnosis of facioscapulohumeral muscular dystrophy.

Authors:  Meena Upadhyaya; David N Cooper
Journal:  Expert Rev Mol Diagn       Date:  2002-03       Impact factor: 5.225

3.  Magnetic resonance imaging of primary skeletal muscle diseases: patterns of distribution and severity of involvement.

Authors:  A E Lamminen
Journal:  Br J Radiol       Date:  1990-12       Impact factor: 3.039

Review 4.  Facioscapulohumeral dystrophy: a distinct regional myopathy with a novel molecular pathogenesis. FSH Consortium.

Authors:  R Tawil; D A Figlewicz; R C Griggs; B Weiffenbach
Journal:  Ann Neurol       Date:  1998-03       Impact factor: 10.422

5.  Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD)

Authors:  P W Lunt; P E Jardine; M C Koch; J Maynard; M Osborn; M Williams; P S Harper; M Upadhyaya
Journal:  Hum Mol Genet       Date:  1995-05       Impact factor: 6.150

6.  Objective quantification of muscle and fat in human dystrophic muscle by magnetic resonance image analysis.

Authors:  J Phoenix; D Betal; N Roberts; T R Helliwell; R H Edwards
Journal:  Muscle Nerve       Date:  1996-03       Impact factor: 3.217

7.  Aerobic training improves exercise performance in facioscapulohumeral muscular dystrophy.

Authors:  David B Olsen; Mette Cathrine Ørngreen; John Vissing
Journal:  Neurology       Date:  2005-03-22       Impact factor: 9.910

8.  Profiles of neuromuscular diseases. Facioscapulohumeral muscular dystrophy.

Authors:  D D Kilmer; R T Abresch; M A McCrory; G T Carter; W M Fowler; E R Johnson; C M McDonald
Journal:  Am J Phys Med Rehabil       Date:  1995 Sep-Oct       Impact factor: 2.159

9.  Location of facioscapulohumeral muscular dystrophy gene on chromosome 4.

Authors:  C Wijmenga; R R Frants; O F Brouwer; P Moerer; J L Weber; G W Padberg
Journal:  Lancet       Date:  1990-09-15       Impact factor: 79.321

10.  Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype.

Authors:  E Ricci; G Galluzzi; G Deidda; S Cacurri; L Colantoni; B Merico; N Piazzo; S Servidei; E Vigneti; V Pasceri; G Silvestri; M Mirabella; F Mangiola; P Tonali; L Felicetti
Journal:  Ann Neurol       Date:  1999-06       Impact factor: 10.422

View more
  24 in total

Review 1.  Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review.

Authors:  Doris G Leung
Journal:  J Neurol       Date:  2016-11-25       Impact factor: 4.849

2.  Adding quantitative muscle MRI to the FSHD clinical trial toolbox.

Authors:  Karlien Mul; Sanne C C Vincenten; Nicol C Voermans; Richard J L F Lemmers; Patrick J van der Vliet; Silvère M van der Maarel; George W Padberg; Corinne G C Horlings; Baziel G M van Engelen
Journal:  Neurology       Date:  2017-10-13       Impact factor: 9.910

3.  Facioscapulohumeral muscular dystrophy presenting with unusual phenotypes and atypical morphological features of vacuolar myopathy.

Authors:  Peter Reilich; Nicolai Schramm; Benedikt Schoser; Peter Schneiderat; Nicola Strigl-Pill; Josef Müller-Höcker; Wolfram Kress; Andreas Ferbert; Sabine Rudnik-Schöneborn; Johannes Noth; Hanns Lochmüller; Joachim Weis; Maggie C Walter
Journal:  J Neurol       Date:  2010-02-10       Impact factor: 4.849

4.  Clinical Muscle Testing Compared with Whole-Body Magnetic Resonance Imaging in Facio-scapulo-humeral Muscular Dystrophy.

Authors:  J U Regula; L Jestaedt; F Jende; A Bartsch; H-M Meinck; M-A Weber
Journal:  Clin Neuroradiol       Date:  2015-04-10       Impact factor: 3.649

5.  Camptocormia phenotype of FSHD: a clinical and MRI study on six patients.

Authors:  Berit Jordan; Katharina Eger; Sabrina Koesling; Stephan Zierz
Journal:  J Neurol       Date:  2010-12-17       Impact factor: 4.849

6.  Muscle MRI findings in facioscapulohumeral muscular dystrophy.

Authors:  Simonetta Gerevini; Marina Scarlato; Lorenzo Maggi; Mariangela Cava; Giandomenico Caliendo; Barbara Pasanisi; Andrea Falini; Stefano Carlo Previtali; Lucia Morandi
Journal:  Eur Radiol       Date:  2015-06-27       Impact factor: 5.315

7.  Permanent muscular sodium overload and persistent muscle edema in Duchenne muscular dystrophy: a possible contributor of progressive muscle degeneration.

Authors:  M-A Weber; A M Nagel; M B Wolf; K Jurkat-Rott; H-U Kauczor; W Semmler; F Lehmann-Horn
Journal:  J Neurol       Date:  2012-04-28       Impact factor: 4.849

8.  CD8(+) T cells in facioscapulohumeral muscular dystrophy patients with inflammatory features at muscle MRI.

Authors:  Giovanni Frisullo; Roberto Frusciante; Viviana Nociti; Giorgio Tasca; Rosaria Renna; Raffaele Iorio; Agata Katia Patanella; Elisabetta Iannaccone; Alessandro Marti; Monica Rossi; Assunta Bianco; Mauro Monforte; Pietro Attilio Tonali; Massimiliano Mirabella; Anna Paola Batocchi; Enzo Ricci
Journal:  J Clin Immunol       Date:  2010-11-10       Impact factor: 8.317

9.  Increased resistance towards fatigability in patients with facioscapulohumeral muscular dystrophy.

Authors:  Matteo Beretta-Piccoli; Luca Calanni; Massimo Negro; Giulia Ricci; Cinzia Bettio; Marco Barbero; Angela Berardinelli; Gabriele Siciliano; Rossella Tupler; Emiliano Soldini; Corrado Cescon; Giuseppe D'Antona
Journal:  Eur J Appl Physiol       Date:  2021-03-01       Impact factor: 3.078

10.  Conditional over-expression of PITX1 causes skeletal muscle dystrophy in mice.

Authors:  Sachchida N Pandey; Jennifer Cabotage; Rongye Shi; Manjusha Dixit; Margret Sutherland; Jian Liu; Stephanie Muger; Scott Q Harper; Kanneboyina Nagaraju; Yi-Wen Chen
Journal:  Biol Open       Date:  2012-05-25       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.